Equities

C Rad AB

C Rad AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)28.55
  • Today's Change-0.45 / -1.55%
  • Shares traded38.41k
  • 1 Year change-19.12%
  • Beta0.9536
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments129122122
Total Receivables, Net165139108
Total Inventory644017
Prepaid expenses6.546.2017
Other current assets, total------
Total current assets365307264
Property, plant & equipment, net111013
Goodwill, net------
Intangibles, net302217
Long term investments------
Note receivable - long term--00
Other long term assets--0.00--
Total assets406339307
LIABILITIES
Accounts payable303123
Accrued expenses414032
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.153.203.05
Other current liabilities, total581812
Total current liabilities1339369
Total long term debt1.754.086.37
Total debt4.907.289.42
Deferred income tax------
Minority interest------
Other liabilities, total--0--
Total liabilities1349776
SHAREHOLDERS EQUITY
Common stock5.075.075.06
Additional paid-in capital379381380
Retained earnings (accumulated deficit)(110)(146)(153)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(2.95)1.65(1.32)
Total equity271243231
Total liabilities & shareholders' equity406339307
Total common shares outstanding343434
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.